`
`CENTER FOR DRUG EVALUATION AND
`RESEARCH
`RESEARCH
`
`
`
`
`
`APPLICATION NUMBER:
`22-288
`22-288
`
`
`APPLICA TION NUMBER:
`
`OFFICER/EMPLOYEE LIST
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`
`
`Employee/Officer List
`Application: NDA 22-288
`
`The following employees of
`
`FDA paricipated in the decision to approve NDA 22-288
`Bepreve (bepotastine besilate ophthalmic solution) 1.5%, consented to be identified:
`
`Allo, Theresa
`Bergman, Kimberly
`Bonapace, Charles
`Boyd, Wiliam
`Brown, Raichell
`Chambers, Wiley
`Chen, Conrad
`Cox, Edward
`Dilon Parker, Maureen
`Holoquist, Carol
`Jenkins, Darell
`Metcalfe, John
`Pagay, Shrikant
`Rashid, Mushfqur
`Rodriguez, Raphael
`Schmidt, Wendelyn
`Schmuff, Norman
`Toyer, Denise
`Wadhwa, Sonal
`Wang, Yan
`
`./
`
`